Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation
Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was s...
Saved in:
Published in: | Immunity (Cambridge, Mass.) Vol. 40; no. 1; pp. 40 - 50 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
16-01-2014
Elsevier Limited Cell Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-γ (IFN-γ), STAT1, or RAG-1. Here, IFN-γ and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation.
•Repeated acute resolving inflammation leads to excessive tissue damage•IL-6 regulates profibrotic IFN-γ-secreting T cells•IFN-γ increases detrimental STAT1 signaling in stromal tissue•STAT1 activity alters homeostatic control of extracellular matrix to promote fibrosis |
---|---|
AbstractList | Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-γ (IFN-γ), STAT1, or RAG-1. Here, IFN-γ and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation.
•
Repeated acute resolving inflammation leads to excessive tissue damage
•
IL-6 regulates profibrotic IFN-γ-secreting T cells
•
IFN-γ increases detrimental STAT1 signaling in stromal tissue
•
STAT1 activity alters homeostatic control of extracellular matrix to promote fibrosis Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-? (IFN-?), STAT1, or RAG-1. Here, IFN-? and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation. Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-γ (IFN-γ), STAT1, or RAG-1. Here, IFN-γ and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation. •Repeated acute resolving inflammation leads to excessive tissue damage•IL-6 regulates profibrotic IFN-γ-secreting T cells•IFN-γ increases detrimental STAT1 signaling in stromal tissue•STAT1 activity alters homeostatic control of extracellular matrix to promote fibrosis Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-γ (IFN-γ), STAT1, or RAG-1. Here, IFN-γ and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation. Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon- gamma (IFN- gamma ), STAT1, or RAG-1. Here, IFN- gamma and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation. |
Author | Uceda, Javier Colmont, Chantal S. Hams, Emily Jones, Simon A. Taylor, Philip R. Hammond, Victoria J. McLeod, Louise Foster, Thomas L. Jenkins, Brendan J. Greenhill, Claire J. Newton, Zarabeth O’Donnell, Valerie B. Fielding, Ceri A. McLoughlin, Rachel M. Coles, Barbara Topley, Nicholas Humphreys, Ian R. Williams, Anwen S. Rice, Christopher M. Craig, Katherine J. Lambie, Mark Williams, John D. Williams, Geraint T. Liao, Chia-Te Kift-Morgan, Ann Davies, Simon J. Jones, Gareth W. |
Author_xml | – sequence: 1 givenname: Ceri A. surname: Fielding fullname: Fielding, Ceri A. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 2 givenname: Gareth W. surname: Jones fullname: Jones, Gareth W. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 3 givenname: Rachel M. surname: McLoughlin fullname: McLoughlin, Rachel M. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 4 givenname: Louise surname: McLeod fullname: McLeod, Louise organization: Centre for Innate Immunity and Infectious Diseases, Monash Institute for Medical Research, Monash University, Clayton, VIC 3168, Australia – sequence: 5 givenname: Victoria J. surname: Hammond fullname: Hammond, Victoria J. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 6 givenname: Javier surname: Uceda fullname: Uceda, Javier organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 7 givenname: Anwen S. surname: Williams fullname: Williams, Anwen S. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 8 givenname: Mark surname: Lambie fullname: Lambie, Mark organization: Department of Nephrology, University Hospital of North Staffordshire and Institute for Science and Technology in Medicine, Keele University, Stoke-on-Trent ST4 7QB, UK – sequence: 9 givenname: Thomas L. surname: Foster fullname: Foster, Thomas L. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 10 givenname: Chia-Te surname: Liao fullname: Liao, Chia-Te organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 11 givenname: Christopher M. surname: Rice fullname: Rice, Christopher M. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 12 givenname: Claire J. surname: Greenhill fullname: Greenhill, Claire J. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 13 givenname: Chantal S. surname: Colmont fullname: Colmont, Chantal S. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 14 givenname: Emily surname: Hams fullname: Hams, Emily organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 15 givenname: Barbara surname: Coles fullname: Coles, Barbara organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 16 givenname: Ann surname: Kift-Morgan fullname: Kift-Morgan, Ann organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 17 givenname: Zarabeth surname: Newton fullname: Newton, Zarabeth organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 18 givenname: Katherine J. surname: Craig fullname: Craig, Katherine J. organization: Institute of Nephrology, Institute of Molecular and Experimental Medicine, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK – sequence: 19 givenname: John D. surname: Williams fullname: Williams, John D. organization: Institute of Nephrology, Institute of Molecular and Experimental Medicine, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK – sequence: 20 givenname: Geraint T. surname: Williams fullname: Williams, Geraint T. organization: Section of Pathology, Institute of Cancer and Genetics, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 21 givenname: Simon J. surname: Davies fullname: Davies, Simon J. organization: Department of Nephrology, University Hospital of North Staffordshire and Institute for Science and Technology in Medicine, Keele University, Stoke-on-Trent ST4 7QB, UK – sequence: 22 givenname: Ian R. surname: Humphreys fullname: Humphreys, Ian R. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 23 givenname: Valerie B. surname: O’Donnell fullname: O’Donnell, Valerie B. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 24 givenname: Philip R. surname: Taylor fullname: Taylor, Philip R. organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 25 givenname: Brendan J. surname: Jenkins fullname: Jenkins, Brendan J. organization: Centre for Innate Immunity and Infectious Diseases, Monash Institute for Medical Research, Monash University, Clayton, VIC 3168, Australia – sequence: 26 givenname: Nicholas surname: Topley fullname: Topley, Nicholas email: topley@cf.ac.uk organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK – sequence: 27 givenname: Simon A. surname: Jones fullname: Jones, Simon A. email: jonessa@cf.ac.uk organization: Cardiff Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24412616$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1v1DAQhi3Uin7AP0AoEhcuWTyOndgXJCgUVqrUQ-nZ8tqTxUtiFztZiX-Poy3l40BPMxq_89p-3jNyFGJAQl4AXQGF9s1u5cdxDn7FKDRltKKMPSGnQFVXc5D0aOk7XnctNCfkLOcdpcCFok_JCeMcWAvtKXm_DhOmAedvPtRtdeO3wQw-bKsPye8xV5d-k2L2ufKhug0Jcxz26Kp16AczjmbyMTwjx70ZMj6_r-fk9vLjl4vP9dX1p_XFu6vaik5MtXJSgRFMGOUUQzTSCcM4Sug3ktKuU4pR7lrKqQPgIIy0fSt7BGksgmnOyduD7928GdFZDFMyg75LfjTph47G679Pgv-qt3GvGwWLdTF4fW-Q4vcZ86RHny0OgwkY56xBNFwCY1I8LuWKqsKdqiJ99Y90F-dUKC6GlLMOmmZR8YPKFpw5Yf_wbqB6yVPv9CFPveS5TEueZe3ln39-WPoV4G8oWMjvPSadrcdg0fmEdtIu-v_f8BMnRbRC |
CitedBy_id | crossref_primary_10_1016_j_jcmgh_2015_12_007 crossref_primary_10_1152_ajplung_00275_2019 crossref_primary_10_1016_j_phrs_2024_107245 crossref_primary_10_1007_s00467_016_3461_y crossref_primary_10_1172_JCI121987 crossref_primary_10_3390_cells12050766 crossref_primary_10_1016_j_ajpath_2017_03_007 crossref_primary_10_1183_13993003_02248_2020 crossref_primary_10_1002_eji_201646528 crossref_primary_10_1515_med_2023_0877 crossref_primary_10_3389_fimmu_2018_01865 crossref_primary_10_1186_s12876_020_01334_8 crossref_primary_10_1016_j_clim_2016_09_002 crossref_primary_10_1016_j_jceh_2022_06_008 crossref_primary_10_3390_ijms21155203 crossref_primary_10_1016_j_dld_2020_08_004 crossref_primary_10_1016_j_jpedp_2017_03_005 crossref_primary_10_1016_j_kint_2016_02_029 crossref_primary_10_1016_j_tcb_2018_04_006 crossref_primary_10_1097_TP_0000000000001227 crossref_primary_10_2106_JBJS_RVW_23_00140 crossref_primary_10_4049_jimmunol_1701211 crossref_primary_10_1016_j_bbmt_2014_07_022 crossref_primary_10_1038_ki_2014_209 crossref_primary_10_1172_jci_insight_120147 crossref_primary_10_3389_fphar_2017_00855 crossref_primary_10_4049_jimmunol_1600990 crossref_primary_10_1152_ajprenal_00425_2019 crossref_primary_10_1155_2019_8106482 crossref_primary_10_2174_1381612828666220422090238 crossref_primary_10_3389_fpsyt_2017_00221 crossref_primary_10_12998_wjcc_v9_i16_3814 crossref_primary_10_3390_cancers12102865 crossref_primary_10_3389_fimmu_2016_00696 crossref_primary_10_1080_16878507_2019_1695392 crossref_primary_10_1016_j_kint_2016_03_040 crossref_primary_10_3390_ijms22073331 crossref_primary_10_4049_jimmunol_1901211 crossref_primary_10_15789_1563_0625_POF_1954 crossref_primary_10_4110_in_2022_22_e51 crossref_primary_10_1007_s13555_023_00916_0 crossref_primary_10_1186_s12964_023_01234_w crossref_primary_10_1007_s00441_017_2576_1 crossref_primary_10_1016_j_cyto_2016_11_006 crossref_primary_10_2337_db20_0604 crossref_primary_10_1042_BSR20170794 crossref_primary_10_1111_cei_13253 crossref_primary_10_3390_cells8030232 crossref_primary_10_3390_ijms24129796 crossref_primary_10_1155_2014_794249 crossref_primary_10_3390_cancers11111736 crossref_primary_10_1016_j_intimp_2016_08_008 crossref_primary_10_1111_sdi_12350 crossref_primary_10_1038_s41598_022_11435_x crossref_primary_10_3945_jn_114_197657 crossref_primary_10_1186_s12967_016_1098_z crossref_primary_10_1186_s12974_022_02546_3 crossref_primary_10_1007_s10157_021_02067_y crossref_primary_10_3389_fmed_2022_836861 crossref_primary_10_1002_ame2_12388 crossref_primary_10_1152_ajplung_00184_2017 crossref_primary_10_1186_s13069_016_0043_3 crossref_primary_10_1111_1744_9987_12391 crossref_primary_10_1016_j_jvssci_2022_04_001 crossref_primary_10_1007_s12026_020_09147_3 crossref_primary_10_1073_pnas_2010275117 crossref_primary_10_1007_s10555_024_10169_8 crossref_primary_10_1093_intimm_dxaa078 crossref_primary_10_1097_PRS_0000000000001177 crossref_primary_10_3390_jcm13123427 crossref_primary_10_1016_j_pdpdt_2020_101967 crossref_primary_10_38181_2223_2427_2023_1_7 crossref_primary_10_3389_fphys_2023_1187207 crossref_primary_10_3390_biomedicines11092408 crossref_primary_10_1538_expanim_16_0043 crossref_primary_10_1177_0896860819896242 crossref_primary_10_3748_wjg_v21_i11_3223 crossref_primary_10_3390_antiox10071050 crossref_primary_10_1080_13543784_2017_1385760 crossref_primary_10_1016_j_kint_2018_03_014 crossref_primary_10_1007_s10787_018_0458_0 crossref_primary_10_1172_JCI122462 crossref_primary_10_3389_fimmu_2023_1257802 crossref_primary_10_33029_0016_9900_2020_99_2_140_144 crossref_primary_10_1038_nrrheum_2017_83 crossref_primary_10_1016_j_ekir_2022_08_008 crossref_primary_10_1038_s41598_017_15198_8 crossref_primary_10_1080_08923973_2022_2047198 crossref_primary_10_25796_bdd_v4i3_62673 crossref_primary_10_5301_jsrd_5000265 crossref_primary_10_1038_s41590_019_0350_0 crossref_primary_10_1124_jpet_114_213520comm crossref_primary_10_3747_pdi_2013_00274 crossref_primary_10_1152_ajprenal_00653_2013 crossref_primary_10_1515_hsz_2020_0125 crossref_primary_10_3389_fimmu_2022_945063 crossref_primary_10_3390_nu13072282 crossref_primary_10_1038_s41435_018_0048_6 crossref_primary_10_1111_bjd_16173 crossref_primary_10_1016_j_kint_2016_10_030 crossref_primary_10_1016_j_ajo_2017_11_025 crossref_primary_10_1016_j_kint_2015_12_005 crossref_primary_10_3389_fonc_2022_812811 crossref_primary_10_3390_biom10121666 crossref_primary_10_1016_j_smim_2015_09_001 crossref_primary_10_1038_srep28261 crossref_primary_10_1038_s41598_020_68495_0 crossref_primary_10_1038_s41590_022_01200_7 crossref_primary_10_2185_jrm_2021_009 crossref_primary_10_1289_EHP7045 crossref_primary_10_1111_sji_12472 crossref_primary_10_3390_ijms18122563 crossref_primary_10_1016_j_injury_2020_06_023 crossref_primary_10_1002_path_5438 crossref_primary_10_3389_fimmu_2024_1370107 crossref_primary_10_1016_j_intimp_2023_110173 crossref_primary_10_1080_01902148_2023_2286465 crossref_primary_10_1007_s00418_020_01923_4 crossref_primary_10_14814_phy2_12443 crossref_primary_10_1080_21691401_2024_2326616 crossref_primary_10_1177_0394632015584733 crossref_primary_10_1038_s41467_021_27766_8 crossref_primary_10_3389_fphar_2022_866077 crossref_primary_10_1007_s12328_023_01782_1 crossref_primary_10_1002_1873_3468_14201 crossref_primary_10_1016_j_jceh_2019_09_006 crossref_primary_10_1038_s41467_018_03050_0 crossref_primary_10_3389_fmolb_2021_708127 crossref_primary_10_1016_j_ekir_2018_12_006 crossref_primary_10_1093_ndt_gfw076 crossref_primary_10_1007_s00018_022_04670_y crossref_primary_10_1097_MIB_0000000000000628 crossref_primary_10_1016_j_cyto_2021_155650 crossref_primary_10_3747_pdi_2016_00290 crossref_primary_10_1186_s12917_019_2215_z crossref_primary_10_3389_fimmu_2024_1371706 crossref_primary_10_1016_j_matbio_2016_01_017 crossref_primary_10_1016_j_matbio_2017_11_010 crossref_primary_10_1016_j_ajpath_2016_07_021 crossref_primary_10_1681_ASN_2015080923 crossref_primary_10_1002_adbi_202200292 crossref_primary_10_1186_s13287_021_02675_1 crossref_primary_10_1093_ndt_gfv092 crossref_primary_10_1038_cdd_2017_31 crossref_primary_10_1128_IAI_00674_13 crossref_primary_10_3389_fimmu_2020_597741 crossref_primary_10_1016_j_kint_2018_12_030 crossref_primary_10_1177_0960327120947453 crossref_primary_10_3390_pathogens11070784 crossref_primary_10_1038_nrrheum_2014_53 crossref_primary_10_1371_journal_ppat_1010724 crossref_primary_10_1038_s41598_017_18003_8 crossref_primary_10_1016_j_lfs_2021_120040 crossref_primary_10_3389_fimmu_2022_999008 crossref_primary_10_1016_j_cyto_2024_156687 crossref_primary_10_12737_article_5b9858ead1b5e3_93619630 crossref_primary_10_1111_jfbc_13819 crossref_primary_10_1152_ajprenal_00428_2016 crossref_primary_10_1016_j_kint_2017_02_037 crossref_primary_10_1016_j_lfs_2017_08_019 crossref_primary_10_53941_ijddp_v1i1_206 crossref_primary_10_1016_j_cbi_2018_08_016 crossref_primary_10_1152_ajprenal_00636_2017 crossref_primary_10_3389_fimmu_2021_607204 crossref_primary_10_1097_PRS_0000000000010224 crossref_primary_10_1093_ndt_gfu233 crossref_primary_10_1186_s12876_019_0933_0 crossref_primary_10_1016_j_biopha_2024_116429 crossref_primary_10_1016_j_jss_2015_04_036 crossref_primary_10_1093_mmy_myz100 crossref_primary_10_1038_s41598_021_82930_w crossref_primary_10_1093_ndt_gfv440 crossref_primary_10_1186_s12989_016_0172_2 crossref_primary_10_1007_s43032_024_01465_3 crossref_primary_10_1177_0896860820982218 crossref_primary_10_18632_oncotarget_14614 crossref_primary_10_1186_s12964_023_01214_0 crossref_primary_10_1097_MOU_0000000000001066 crossref_primary_10_1007_s10753_023_01810_9 crossref_primary_10_1016_j_nbd_2014_10_024 crossref_primary_10_1016_j_cyto_2021_155520 crossref_primary_10_1007_s00210_020_01961_8 crossref_primary_10_1093_infdis_jiw287 crossref_primary_10_1093_cvr_cvz164 crossref_primary_10_1681_ASN_2015101169 crossref_primary_10_1101_gad_345629_120 crossref_primary_10_1002_ctm2_1545 crossref_primary_10_1111_1751_7915_13467 crossref_primary_10_1093_gerona_glac148 crossref_primary_10_1016_j_crphar_2021_100023 crossref_primary_10_1016_j_amjcard_2021_11_045 crossref_primary_10_3389_fimmu_2023_1117630 crossref_primary_10_3390_ijms241512210 crossref_primary_10_1210_en_2017_00489 crossref_primary_10_1002_ptr_6857 crossref_primary_10_1016_j_cyto_2018_04_025 crossref_primary_10_1136_jitc_2021_002460 crossref_primary_10_1155_2021_6625955 crossref_primary_10_1152_ajpheart_00608_2015 crossref_primary_10_1016_j_ijrobp_2018_10_007 crossref_primary_10_1007_s00204_014_1428_y crossref_primary_10_1038_s41598_017_05780_5 crossref_primary_10_4049_jimmunol_2300114 crossref_primary_10_1097_TP_0000000000002181 crossref_primary_10_1016_j_dld_2020_07_010 crossref_primary_10_1038_s41598_023_30149_2 crossref_primary_10_3389_fimmu_2020_01142 crossref_primary_10_1177_08968608221133629 crossref_primary_10_1002_term_2837 crossref_primary_10_1093_cvr_cvy013 crossref_primary_10_1177_03000605231197058 crossref_primary_10_1186_s12893_016_0196_4 crossref_primary_10_3389_fphys_2018_01692 crossref_primary_10_1084_jem_20181074 crossref_primary_10_1183_23120541_00390_2020 crossref_primary_10_1038_s41577_018_0066_7 crossref_primary_10_1016_j_kint_2017_03_030 crossref_primary_10_1038_s41433_019_0374_6 crossref_primary_10_1080_03007995_2023_2281501 crossref_primary_10_1016_j_ctarc_2023_100684 crossref_primary_10_1155_2023_4848643 crossref_primary_10_1152_ajplung_00238_2014 crossref_primary_10_1182_blood_2016_07_727180 crossref_primary_10_1002_hep_31755 crossref_primary_10_3390_ijms241813765 crossref_primary_10_3389_fimmu_2017_00254 crossref_primary_10_1155_2021_6666441 crossref_primary_10_1016_j_cyto_2019_154767 crossref_primary_10_1093_rheumatology_kex347 crossref_primary_10_4081_ecj_2020_9105 crossref_primary_10_1016_j_jsbmb_2017_01_010 crossref_primary_10_1016_j_cellsig_2020_109770 crossref_primary_10_1016_j_addr_2021_113831 crossref_primary_10_1038_s41467_021_22617_y crossref_primary_10_1093_molehr_gaad037 crossref_primary_10_1016_j_cellsig_2020_109778 crossref_primary_10_1016_j_bioadv_2022_213165 crossref_primary_10_1007_s11427_016_0240_4 crossref_primary_10_1067_j_cpsurg_2015_05_001 crossref_primary_10_1007_s11926_018_0712_x crossref_primary_10_1152_ajprenal_00319_2019 crossref_primary_10_1002_JLB_3MR0821_147R crossref_primary_10_1038_ni_3153 crossref_primary_10_1155_2014_137049 crossref_primary_10_1371_journal_ppat_1010471 crossref_primary_10_1016_j_cyto_2021_155684 crossref_primary_10_1155_2020_9137251 crossref_primary_10_33549_physiolres_934158 crossref_primary_10_1016_j_kint_2018_09_012 crossref_primary_10_1038_s41598_022_25471_0 crossref_primary_10_4236_jbnb_2019_104012 crossref_primary_10_1080_15384101_2016_1152435 crossref_primary_10_2217_nnm_2022_0231 crossref_primary_10_1038_s41413_019_0047_x crossref_primary_10_1053_j_ajkd_2014_06_030 crossref_primary_10_1186_s12931_020_1319_0 crossref_primary_10_3389_fimmu_2024_1387292 crossref_primary_10_1172_jci_insight_97818 crossref_primary_10_1016_j_jped_2016_11_009 crossref_primary_10_1016_j_ebiom_2020_102661 crossref_primary_10_1038_srep29884 crossref_primary_10_4049_jimmunol_1303048 crossref_primary_10_1155_2016_3543678 |
Cites_doi | 10.1046/j.1523-1755.1999.00775.x 10.1172/JCI5909 10.1038/mi.2012.2 10.1038/nrmicro732 10.1093/ndt/gfr217 10.1073/pnas.0501794102 10.4049/jimmunol.181.7.5089 10.1016/S0264-410X(98)00223-0 10.4049/jimmunol.175.1.131 10.1165/rcmb.2007-0365OC 10.1016/j.coph.2004.03.005 10.1126/science.1078231 10.4049/jimmunol.182.1.613 10.1038/nri1412 10.4049/jimmunol.152.7.3606 10.1056/NEJMoa073687 10.1172/JCI17129 10.1093/intimm/dxm037 10.1038/ni1537 10.1172/JCI0215841 10.1002/path.2277 10.1038/368339a0 10.4049/jimmunol.171.11.6198 10.4049/jimmunol.175.6.3463 10.1016/j.ccr.2009.01.002 10.4049/jimmunol.181.3.2189 10.1182/blood-2006-08-040352 10.1038/nature06096 10.4049/jimmunol.180.1.647 10.1084/jem.20030077 10.1073/pnas.83.12.4167 10.1038/nm1282 10.4049/jimmunol.181.10.7243 10.1038/324073a0 10.1681/ASN.V1251046 10.4049/jimmunol.1002971 10.1089/jir.2007.0103 10.4049/jimmunol.0901528 10.1681/ASN.V132470 10.1053/j.gastro.2006.04.025 10.1016/S0092-8674(00)81730-4 10.1128/iai.61.2.399-410.1993 10.1016/S1074-7613(01)00151-0 10.1053/j.gastro.2006.07.018 10.1002/eji.200636483 10.1016/S1074-7613(00)00078-9 10.1016/j.ccr.2009.01.001 10.4049/jimmunol.164.9.4878 10.1084/jem.185.3.461 10.1093/oxfordjournals.ndt.a027318 10.1172/JCI200522433 10.1172/JCI57158 10.1053/j.gastro.2005.10.051 10.1371/journal.ppat.1000006 10.1016/j.humimm.2005.01.012 10.4049/jimmunol.1001431 10.4049/jimmunol.179.4.2041 10.1172/JCI31487 10.3109/01902149509050842 10.1038/376594a0 |
ContentType | Journal Article |
Copyright | 2014 Elsevier Inc. Copyright © 2014 Elsevier Inc. All rights reserved. Copyright Elsevier Limited Jan 16, 2014 2014 ELL & Excerpta Medica. 2014 Elsevier Inc. |
Copyright_xml | – notice: 2014 Elsevier Inc. – notice: Copyright © 2014 Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Jan 16, 2014 – notice: 2014 ELL & Excerpta Medica. 2014 Elsevier Inc. |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7QP 7QR 7T5 7T7 7TK 7TM 7U9 8FD C1K FR3 H94 K9. M7N NAPCQ P64 RC3 7X8 5PM |
DOI | 10.1016/j.immuni.2013.10.022 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Technology Research Database Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Nursing & Allied Health Premium Genetics Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1097-4180 |
EndPage | 50 |
ExternalDocumentID | 3236923071 10_1016_j_immuni_2013_10_022 24412616 S107476131300561X |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Wellcome Trust – fundername: Wellcome Trust grantid: 065961 – fundername: Arthritis Research UK grantid: 18286 – fundername: Medical Research Council grantid: G0601617 – fundername: Wellcome Trust grantid: 079044 – fundername: Medical Research Council grantid: MR/J002151/1 – fundername: Versus Arthritis grantid: 20305 – fundername: Arthritis Research UK grantid: 19381 – fundername: Wellcome Trust grantid: 069630 – fundername: Arthritis Research UK grantid: 20305 |
GroupedDBID | --- --K -DZ 0R~ 1RT 1~5 2WC 3V. 4.4 457 4G. 53G 5GY 5VS 62- 6I. 7-5 7RV 7X7 8C1 8FE 8FH AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKRW AAQFI AAUCE AAVLU AAXJY AAXUO ABMAC ABMWF ABOCM ABVKL ACGFO ACGFS ACIWK ACPRK ADBBV ADEZE ADFRT ADJPV AEFWE AENEX AEXQZ AFKRA AFRAH AFTJW AGGSO AGHFR AGKMS AHMBA AITUG ALKID ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BAWUL BBNVY BENPR BHPHI BKEYQ BPHCQ BVXVI C45 CS3 DIK DU5 E3Z EBS EJD F5P FCP FDB FIRID HCIFZ IH2 IHE IXB J1W JIG LK8 LX5 M2O M3Z M41 M7P N9A NCXOZ O-L O9- OK1 OVD P2P PQQKQ PROAC RCE RIG ROL RPZ SCP SES SSZ TEORI TR2 WQ6 ZA5 0SF AALRI AAMRU ADVLN AKAPO AKRWK CGR CUY CVF ECM EIF NPM .55 .GJ 29I AAQXK AAYXX ADMUD AHHHB CITATION FEDTE FGOYB G-2 HVGLF HZ~ OHT OZT R2- UHS X7M Y6R ZGI 7QL 7QP 7QR 7T5 7T7 7TK 7TM 7U9 8FD C1K FR3 H94 K9. M7N NAPCQ P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c575t-9d891a525a9d92eea8d5a24e81fb8007799204d6040d11415a8cf68fe18ace1a3 |
ISSN | 1074-7613 |
IngestDate | Tue Sep 17 21:22:59 EDT 2024 Thu Oct 24 22:49:30 EDT 2024 Sat Oct 05 04:45:40 EDT 2024 Thu Oct 10 22:01:45 EDT 2024 Thu Sep 26 17:23:40 EDT 2024 Sat Sep 28 08:22:28 EDT 2024 Fri Feb 23 02:28:44 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | http://creativecommons.org/licenses/by/3.0 Copyright © 2014 Elsevier Inc. All rights reserved. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/3.0/). |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c575t-9d891a525a9d92eea8d5a24e81fb8007799204d6040d11415a8cf68fe18ace1a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 Present address: School of Biochemistry & Immunology, Trinity College Dublin, Dublin, Ireland These authors contributed equally to this work These authors contributed equally to this work and are co-senior authors Present address: Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3919204 |
PMID | 24412616 |
PQID | 1504271339 |
PQPubID | 2031079 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3919204 proquest_miscellaneous_1534812285 proquest_miscellaneous_1490901309 proquest_journals_1504271339 crossref_primary_10_1016_j_immuni_2013_10_022 pubmed_primary_24412616 elsevier_sciencedirect_doi_10_1016_j_immuni_2013_10_022 |
PublicationCentury | 2000 |
PublicationDate | 2014-01-16 |
PublicationDateYYYYMMDD | 2014-01-16 |
PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-16 day: 16 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Cambridge |
PublicationTitle | Immunity (Cambridge, Mass.) |
PublicationTitleAlternate | Immunity |
PublicationYear | 2014 |
Publisher | Elsevier Inc Elsevier Limited Cell Press |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited – name: Cell Press |
References | Ogata, Kobayashi, Chinen, Takaki, Sanada, Minoda, Koga, Takaesu, Maehara, Iida, Yoshimura (bib44) 2006; 131 Yamamoto, Yoshizaki, Kishimoto, Ito (bib58) 2000; 164 Dienz, Rud, Eaton, Lanthier, Burg, Drew, Bunn, Suratt, Haynes, Rincon (bib11) 2012; 5 Fielding, McLoughlin, McLeod, Colmont, Najdovska, Grail, Ernst, Jones, Topley, Jenkins (bib14) 2008; 181 Davies, Bryan, Phillips, Russell (bib7) 1996; 11 Roberts, Sporn, Assoian, Smith, Roche, Wakefield, Heine, Liotta, Falanga, Kehrl (bib50) 1986; 83 Hirano, Yasukawa, Harada, Taga, Watanabe, Matsuda, Kashiwamura, Nakajima, Koyama, Iwamatsu (bib19) 1986; 324 Barr, Brown, Mastroeni, Gray (bib2) 2010; 185 Kano, Wolfgang, Gao, Jacoby, Chai, Hansen, Iwamoto, Pober, Flavell, Fu (bib31) 2003; 198 Matsukawa, Takeda, Kudo, Maeda, Kagayama, Akira (bib35) 2003; 171 Davies, Phillips, Naish, Russell (bib8) 2001; 12 Stumhofer, Silver, Laurence, Porrett, Harris, Turka, Ernst, Saris, O’Shea, Hunter (bib52) 2007; 8 Wynn (bib54) 2004; 4 Chinen, Kobayashi, Ogata, Takaesu, Takaki, Hashimoto, Yagita, Nawata, Yoshimura (bib5) 2006; 130 Greenhill, Rose-John, Lissilaa, Ferlin, Ernst, Hertzog, Mansell, Jenkins (bib16) 2011; 186 Mozaffarian, Brewer, Trueblood, Luzina, Todd, Atamas, Arnett (bib40) 2008; 181 Williams, Craig, Topley, Von Ruhland, Fallon, Newman, Mackenzie, Williams (bib53) 2002; 13 Mills, Barnard, Watkins, Redhead (bib38) 1993; 61 Doganci, Eigenbrod, Krug, De Sanctis, Hausding, Erpenbeck, Haddad, Lehr, Schmitt, Bopp (bib12) 2005; 115 Wynn (bib56) 2008; 214 Jones (bib27) 2005; 175 Grivennikov, Karin, Terzic, Mucida, Yu, Vallabhapurapu, Scheller, Rose-John, Cheroutre, Eckmann, Karin (bib17) 2009; 15 Wynn, Cheever, Jankovic, Poindexter, Caspar, Lewis, Sher (bib57) 1995; 376 Holland, DeLeo, Elloumi, Hsu, Uzel, Brodsky, Freeman, Demidowich, Davis, Turner (bib21) 2007; 357 Diehl, Anguita, Hoffmeyer, Zapton, Ihle, Fikrig, Rincón (bib10) 2000; 13 McLoughlin, Jenkins, Grail, Williams, Fielding, Parker, Ernst, Topley, Jones (bib37) 2005; 102 Judd, Bredin, Kalantzis, Jenkins, Ernst, Giraud (bib30) 2006; 131 Barr, Brown, Ryan, Zhao, Gray (bib1) 2007; 37 Jenkins, Roberts, Greenhill, Najdovska, Lundgren-May, Robb, Grail, Ernst (bib26) 2007; 109 Lee, Youn, Seong, Sung (bib33) 1999; 17 Kopf, Baumann, Freer, Freudenberg, Lamers, Kishimoto, Zinkernagel, Bluethmann, Köhler (bib32) 1994; 368 Quinton, Jones, Robson, Simms, Whitsett, Mizgerd (bib48) 2008; 38 Wynn (bib55) 2007; 117 Finotto, Eigenbrod, Karwot, Boross, Doganci, Ito, Nishimoto, Yoshizaki, Kishimoto, Rose-John (bib15) 2007; 19 Zhu, Homer, Wang, Chen, Geba, Wang, Zhang, Elias (bib60) 1999; 103 Hong, Jaruga, Kim, Radaeva, El-Assal, Tian, Nguyen, Gao (bib22) 2002; 110 Puel, Picard, Lorrot, Pons, Chrabieh, Lorenzo, Mamani-Matsuda, Jouanguy, Gendrel, Casanova (bib47) 2008; 180 Dominitzki, Fantini, Neufert, Nikolaev, Galle, Scheller, Monteleone, Rose-John, Neurath, Becker (bib13) 2007; 179 Oldroyd, Thomas, Gabbiani, El Nahas (bib45) 1999; 56 Rincón, Anguita, Nakamura, Fikrig, Flavell (bib49) 1997; 185 Hu, Ho, Lou, Hidaka, Ivashkiv (bib23) 2005; 175 Sempowski, Beckmann, Derdak, Phipps (bib51) 1994; 152 Minegishi, Saito, Tsuchiya, Tsuge, Takada, Hara, Kawamura, Ariga, Pasic, Stojkovic (bib39) 2007; 448 Ho, Antoniv, Ji, Ivashkiv (bib20) 2008; 181 Hurst, Wilkinson, McLoughlin, Jones, Horiuchi, Yamamoto, Rose-John, Fuller, Topley, Jones (bib24) 2001; 14 McLoughlin, Witowski, Robson, Wilkinson, Hurst, Williams, Williams, Rose-John, Jones, Topley (bib36) 2003; 112 Murphy, Davis, Brown, Carmichael, Ghaffar, Mayer (bib41) 2008; 28 Jenkins, Grail, Nheu, Najdovska, Wang, Waring, Inglese, McLoughlin, Jones, Topley (bib25) 2005; 11 Nishimoto, Kishimoto (bib42) 2004; 4 Bollrath, Phesse, von Burstin, Putoczki, Bennecke, Bateman, Nebelsiek, Lundgren-May, Canli, Schwitalla (bib3) 2009; 15 Nowell, Williams, Carty, Scheller, Hayes, Jones, Richards, Slinn, Ernst, Jenkins (bib43) 2009; 182 Casadevall, Pirofski (bib4) 2003; 1 Zhu, Richardson, Parada, Graff (bib59) 1998; 94 Colmont, Raby, Dioszeghy, Lebouder, Foster, Jones, Labéta, Fielding, Topley (bib6) 2011; 26 Longhi, Wright, Lauder, Nowell, Jones, Godkin, Jones, Gallimore (bib34) 2008; 4 Detournay, Mazouz, Goldman, Toungouz (bib9) 2005; 66 Gurujeyalakshmi, Giri (bib18) 1995; 21 Jones, Scheller, Rose-John (bib29) 2011; 121 Pasare, Medzhitov (bib46) 2003; 299 Jones, McLoughlin, Hammond, Parker, Williams, Malhotra, Scheller, Williams, Rose-John, Topley, Jones (bib28) 2010; 184 Sempowski (10.1016/j.immuni.2013.10.022_bib51) 1994; 152 Davies (10.1016/j.immuni.2013.10.022_bib7) 1996; 11 Wynn (10.1016/j.immuni.2013.10.022_bib57) 1995; 376 Finotto (10.1016/j.immuni.2013.10.022_bib15) 2007; 19 Greenhill (10.1016/j.immuni.2013.10.022_bib16) 2011; 186 Chinen (10.1016/j.immuni.2013.10.022_bib5) 2006; 130 Doganci (10.1016/j.immuni.2013.10.022_bib12) 2005; 115 Murphy (10.1016/j.immuni.2013.10.022_bib41) 2008; 28 Lee (10.1016/j.immuni.2013.10.022_bib33) 1999; 17 Hong (10.1016/j.immuni.2013.10.022_bib22) 2002; 110 Hirano (10.1016/j.immuni.2013.10.022_bib19) 1986; 324 Quinton (10.1016/j.immuni.2013.10.022_bib48) 2008; 38 Yamamoto (10.1016/j.immuni.2013.10.022_bib58) 2000; 164 Pasare (10.1016/j.immuni.2013.10.022_bib46) 2003; 299 Stumhofer (10.1016/j.immuni.2013.10.022_bib52) 2007; 8 Williams (10.1016/j.immuni.2013.10.022_bib53) 2002; 13 Detournay (10.1016/j.immuni.2013.10.022_bib9) 2005; 66 Dienz (10.1016/j.immuni.2013.10.022_bib11) 2012; 5 McLoughlin (10.1016/j.immuni.2013.10.022_bib37) 2005; 102 Kano (10.1016/j.immuni.2013.10.022_bib31) 2003; 198 Jenkins (10.1016/j.immuni.2013.10.022_bib25) 2005; 11 Fielding (10.1016/j.immuni.2013.10.022_bib14) 2008; 181 Mozaffarian (10.1016/j.immuni.2013.10.022_bib40) 2008; 181 Nishimoto (10.1016/j.immuni.2013.10.022_bib42) 2004; 4 Barr (10.1016/j.immuni.2013.10.022_bib1) 2007; 37 Nowell (10.1016/j.immuni.2013.10.022_bib43) 2009; 182 Casadevall (10.1016/j.immuni.2013.10.022_bib4) 2003; 1 Jenkins (10.1016/j.immuni.2013.10.022_bib26) 2007; 109 Rincón (10.1016/j.immuni.2013.10.022_bib49) 1997; 185 Grivennikov (10.1016/j.immuni.2013.10.022_bib17) 2009; 15 Ogata (10.1016/j.immuni.2013.10.022_bib44) 2006; 131 Jones (10.1016/j.immuni.2013.10.022_bib29) 2011; 121 Zhu (10.1016/j.immuni.2013.10.022_bib59) 1998; 94 Barr (10.1016/j.immuni.2013.10.022_bib2) 2010; 185 Wynn (10.1016/j.immuni.2013.10.022_bib55) 2007; 117 Zhu (10.1016/j.immuni.2013.10.022_bib60) 1999; 103 Jones (10.1016/j.immuni.2013.10.022_bib28) 2010; 184 Judd (10.1016/j.immuni.2013.10.022_bib30) 2006; 131 Matsukawa (10.1016/j.immuni.2013.10.022_bib35) 2003; 171 Colmont (10.1016/j.immuni.2013.10.022_bib6) 2011; 26 Diehl (10.1016/j.immuni.2013.10.022_bib10) 2000; 13 Puel (10.1016/j.immuni.2013.10.022_bib47) 2008; 180 Bollrath (10.1016/j.immuni.2013.10.022_bib3) 2009; 15 Davies (10.1016/j.immuni.2013.10.022_bib8) 2001; 12 Jones (10.1016/j.immuni.2013.10.022_bib27) 2005; 175 Minegishi (10.1016/j.immuni.2013.10.022_bib39) 2007; 448 Ho (10.1016/j.immuni.2013.10.022_bib20) 2008; 181 Oldroyd (10.1016/j.immuni.2013.10.022_bib45) 1999; 56 Wynn (10.1016/j.immuni.2013.10.022_bib56) 2008; 214 Kopf (10.1016/j.immuni.2013.10.022_bib32) 1994; 368 Roberts (10.1016/j.immuni.2013.10.022_bib50) 1986; 83 Dominitzki (10.1016/j.immuni.2013.10.022_bib13) 2007; 179 McLoughlin (10.1016/j.immuni.2013.10.022_bib36) 2003; 112 Hurst (10.1016/j.immuni.2013.10.022_bib24) 2001; 14 Mills (10.1016/j.immuni.2013.10.022_bib38) 1993; 61 Holland (10.1016/j.immuni.2013.10.022_bib21) 2007; 357 Longhi (10.1016/j.immuni.2013.10.022_bib34) 2008; 4 Wynn (10.1016/j.immuni.2013.10.022_bib54) 2004; 4 Hu (10.1016/j.immuni.2013.10.022_bib23) 2005; 175 Gurujeyalakshmi (10.1016/j.immuni.2013.10.022_bib18) 1995; 21 |
References_xml | – volume: 5 start-page: 258 year: 2012 end-page: 266 ident: bib11 article-title: Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung publication-title: Mucosal Immunol. contributor: fullname: Rincon – volume: 180 start-page: 647 year: 2008 end-page: 654 ident: bib47 article-title: Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6 publication-title: J. Immunol. contributor: fullname: Casanova – volume: 109 start-page: 2380 year: 2007 end-page: 2388 ident: bib26 article-title: Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis publication-title: Blood contributor: fullname: Ernst – volume: 17 start-page: 490 year: 1999 end-page: 496 ident: bib33 article-title: IL-6 induces long-term protective immunity against a lethal challenge of influenza virus publication-title: Vaccine contributor: fullname: Sung – volume: 21 start-page: 791 year: 1995 end-page: 808 ident: bib18 article-title: Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression publication-title: Exp. Lung Res. contributor: fullname: Giri – volume: 94 start-page: 703 year: 1998 end-page: 714 ident: bib59 article-title: Smad3 mutant mice develop metastatic colorectal cancer publication-title: Cell contributor: fullname: Graff – volume: 175 start-page: 3463 year: 2005 end-page: 3468 ident: bib27 article-title: Directing transition from innate to acquired immunity: defining a role for IL-6 publication-title: J. Immunol. contributor: fullname: Jones – volume: 112 start-page: 598 year: 2003 end-page: 607 ident: bib36 article-title: Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation publication-title: J. Clin. Invest. contributor: fullname: Topley – volume: 152 start-page: 3606 year: 1994 end-page: 3614 ident: bib51 article-title: Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis publication-title: J. Immunol. contributor: fullname: Phipps – volume: 131 start-page: 179 year: 2006 end-page: 193 ident: bib44 article-title: Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis publication-title: Gastroenterology contributor: fullname: Yoshimura – volume: 12 start-page: 1046 year: 2001 end-page: 1051 ident: bib8 article-title: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis publication-title: J. Am. Soc. Nephrol. contributor: fullname: Russell – volume: 368 start-page: 339 year: 1994 end-page: 342 ident: bib32 article-title: Impaired immune and acute-phase responses in interleukin-6-deficient mice publication-title: Nature contributor: fullname: Köhler – volume: 214 start-page: 199 year: 2008 end-page: 210 ident: bib56 article-title: Cellular and molecular mechanisms of fibrosis publication-title: J. Pathol. contributor: fullname: Wynn – volume: 164 start-page: 4878 year: 2000 end-page: 4882 ident: bib58 article-title: IL-6 is required for the development of Th1 cell-mediated murine colitis publication-title: J. Immunol. contributor: fullname: Ito – volume: 1 start-page: 17 year: 2003 end-page: 24 ident: bib4 article-title: The damage-response framework of microbial pathogenesis publication-title: Nat. Rev. Microbiol. contributor: fullname: Pirofski – volume: 37 start-page: 3040 year: 2007 end-page: 3053 ident: bib1 article-title: TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells publication-title: Eur. J. Immunol. contributor: fullname: Gray – volume: 115 start-page: 313 year: 2005 end-page: 325 ident: bib12 article-title: The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo publication-title: J. Clin. Invest. contributor: fullname: Bopp – volume: 184 start-page: 2130 year: 2010 end-page: 2139 ident: bib28 article-title: Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells publication-title: J. Immunol. contributor: fullname: Jones – volume: 198 start-page: 1517 year: 2003 end-page: 1525 ident: bib31 article-title: Endothelial cells require STAT3 for protection against endotoxin-induced inflammation publication-title: J. Exp. Med. contributor: fullname: Fu – volume: 15 start-page: 91 year: 2009 end-page: 102 ident: bib3 article-title: gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis publication-title: Cancer Cell contributor: fullname: Schwitalla – volume: 4 start-page: 583 year: 2004 end-page: 594 ident: bib54 article-title: Fibrotic disease and the T(H)1/T(H)2 paradigm publication-title: Nat. Rev. Immunol. contributor: fullname: Wynn – volume: 181 start-page: 5089 year: 2008 end-page: 5097 ident: bib20 article-title: Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1 publication-title: J. Immunol. contributor: fullname: Ivashkiv – volume: 171 start-page: 6198 year: 2003 end-page: 6205 ident: bib35 article-title: Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils publication-title: J. Immunol. contributor: fullname: Akira – volume: 38 start-page: 699 year: 2008 end-page: 706 ident: bib48 article-title: Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during publication-title: Am. J. Respir. Cell Mol. Biol. contributor: fullname: Mizgerd – volume: 181 start-page: 7243 year: 2008 end-page: 7253 ident: bib40 article-title: Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis publication-title: J. Immunol. contributor: fullname: Arnett – volume: 103 start-page: 779 year: 1999 end-page: 788 ident: bib60 article-title: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production publication-title: J. Clin. Invest. contributor: fullname: Elias – volume: 448 start-page: 1058 year: 2007 end-page: 1062 ident: bib39 article-title: Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome publication-title: Nature contributor: fullname: Stojkovic – volume: 185 start-page: 2783 year: 2010 end-page: 2789 ident: bib2 article-title: TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to publication-title: J. Immunol. contributor: fullname: Gray – volume: 19 start-page: 685 year: 2007 end-page: 693 ident: bib15 article-title: Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells publication-title: Int. Immunol. contributor: fullname: Rose-John – volume: 131 start-page: 1073 year: 2006 end-page: 1085 ident: bib30 article-title: STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis publication-title: Gastroenterology contributor: fullname: Giraud – volume: 175 start-page: 131 year: 2005 end-page: 138 ident: bib23 article-title: Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction publication-title: J. Immunol. contributor: fullname: Ivashkiv – volume: 13 start-page: 470 year: 2002 end-page: 479 ident: bib53 article-title: Morphologic changes in the peritoneal membrane of patients with renal disease publication-title: J. Am. Soc. Nephrol. contributor: fullname: Williams – volume: 11 start-page: 498 year: 1996 end-page: 506 ident: bib7 article-title: Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis publication-title: Nephrol. Dial. Transplant. contributor: fullname: Russell – volume: 83 start-page: 4167 year: 1986 end-page: 4171 ident: bib50 article-title: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro publication-title: Proc. Natl. Acad. Sci. USA contributor: fullname: Kehrl – volume: 117 start-page: 524 year: 2007 end-page: 529 ident: bib55 article-title: Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases publication-title: J. Clin. Invest. contributor: fullname: Wynn – volume: 13 start-page: 805 year: 2000 end-page: 815 ident: bib10 article-title: Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1 publication-title: Immunity contributor: fullname: Rincón – volume: 179 start-page: 2041 year: 2007 end-page: 2045 ident: bib13 article-title: Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells publication-title: J. Immunol. contributor: fullname: Becker – volume: 11 start-page: 845 year: 2005 end-page: 852 ident: bib25 article-title: Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling publication-title: Nat. Med. contributor: fullname: Topley – volume: 130 start-page: 373 year: 2006 end-page: 388 ident: bib5 article-title: Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved publication-title: Gastroenterology contributor: fullname: Yoshimura – volume: 186 start-page: 1199 year: 2011 end-page: 1208 ident: bib16 article-title: IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3 publication-title: J. Immunol. contributor: fullname: Jenkins – volume: 8 start-page: 1363 year: 2007 end-page: 1371 ident: bib52 article-title: Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 publication-title: Nat. Immunol. contributor: fullname: Hunter – volume: 4 start-page: e1000006 year: 2008 ident: bib34 article-title: Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells publication-title: PLoS Pathog. contributor: fullname: Gallimore – volume: 66 start-page: 460 year: 2005 end-page: 468 ident: bib9 article-title: IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells publication-title: Hum. Immunol. contributor: fullname: Toungouz – volume: 181 start-page: 2189 year: 2008 end-page: 2195 ident: bib14 article-title: IL-6 regulates neutrophil trafficking during acute inflammation via STAT3 publication-title: J. Immunol. contributor: fullname: Jenkins – volume: 185 start-page: 461 year: 1997 end-page: 469 ident: bib49 article-title: Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells publication-title: J. Exp. Med. contributor: fullname: Flavell – volume: 110 start-page: 1503 year: 2002 end-page: 1513 ident: bib22 article-title: Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS publication-title: J. Clin. Invest. contributor: fullname: Gao – volume: 15 start-page: 103 year: 2009 end-page: 113 ident: bib17 article-title: IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer publication-title: Cancer Cell contributor: fullname: Karin – volume: 61 start-page: 399 year: 1993 end-page: 410 ident: bib38 article-title: Cell-mediated immunity to publication-title: Infect. Immun. contributor: fullname: Redhead – volume: 14 start-page: 705 year: 2001 end-page: 714 ident: bib24 article-title: IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation publication-title: Immunity contributor: fullname: Jones – volume: 56 start-page: 2116 year: 1999 end-page: 2127 ident: bib45 article-title: Interferon-gamma inhibits experimental renal fibrosis publication-title: Kidney Int. contributor: fullname: El Nahas – volume: 299 start-page: 1033 year: 2003 end-page: 1036 ident: bib46 article-title: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells publication-title: Science contributor: fullname: Medzhitov – volume: 102 start-page: 9589 year: 2005 end-page: 9594 ident: bib37 article-title: IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation publication-title: Proc. Natl. Acad. Sci. USA contributor: fullname: Jones – volume: 4 start-page: 386 year: 2004 end-page: 391 ident: bib42 article-title: Inhibition of IL-6 for the treatment of inflammatory diseases publication-title: Curr. Opin. Pharmacol. contributor: fullname: Kishimoto – volume: 28 start-page: 589 year: 2008 end-page: 595 ident: bib41 article-title: Effect of IL-6 deficiency on susceptibility to HSV-1 respiratory infection and intrinsic macrophage antiviral resistance publication-title: J. Interferon Cytokine Res. contributor: fullname: Mayer – volume: 182 start-page: 613 year: 2009 end-page: 622 ident: bib43 article-title: Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis publication-title: J. Immunol. contributor: fullname: Jenkins – volume: 26 start-page: 4079 year: 2011 end-page: 4090 ident: bib6 article-title: Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors publication-title: Nephrol. Dial. Transplant. contributor: fullname: Topley – volume: 121 start-page: 3375 year: 2011 end-page: 3383 ident: bib29 article-title: Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling publication-title: J. Clin. Invest. contributor: fullname: Rose-John – volume: 357 start-page: 1608 year: 2007 end-page: 1619 ident: bib21 article-title: STAT3 mutations in the hyper-IgE syndrome publication-title: N. Engl. J. Med. contributor: fullname: Turner – volume: 324 start-page: 73 year: 1986 end-page: 76 ident: bib19 article-title: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin publication-title: Nature contributor: fullname: Iwamatsu – volume: 376 start-page: 594 year: 1995 end-page: 596 ident: bib57 article-title: An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection publication-title: Nature contributor: fullname: Sher – volume: 56 start-page: 2116 year: 1999 ident: 10.1016/j.immuni.2013.10.022_bib45 article-title: Interferon-gamma inhibits experimental renal fibrosis publication-title: Kidney Int. doi: 10.1046/j.1523-1755.1999.00775.x contributor: fullname: Oldroyd – volume: 103 start-page: 779 year: 1999 ident: 10.1016/j.immuni.2013.10.022_bib60 article-title: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production publication-title: J. Clin. Invest. doi: 10.1172/JCI5909 contributor: fullname: Zhu – volume: 5 start-page: 258 year: 2012 ident: 10.1016/j.immuni.2013.10.022_bib11 article-title: Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung publication-title: Mucosal Immunol. doi: 10.1038/mi.2012.2 contributor: fullname: Dienz – volume: 1 start-page: 17 year: 2003 ident: 10.1016/j.immuni.2013.10.022_bib4 article-title: The damage-response framework of microbial pathogenesis publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro732 contributor: fullname: Casadevall – volume: 26 start-page: 4079 year: 2011 ident: 10.1016/j.immuni.2013.10.022_bib6 article-title: Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfr217 contributor: fullname: Colmont – volume: 102 start-page: 9589 year: 2005 ident: 10.1016/j.immuni.2013.10.022_bib37 article-title: IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0501794102 contributor: fullname: McLoughlin – volume: 181 start-page: 5089 year: 2008 ident: 10.1016/j.immuni.2013.10.022_bib20 article-title: Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1 publication-title: J. Immunol. doi: 10.4049/jimmunol.181.7.5089 contributor: fullname: Ho – volume: 17 start-page: 490 year: 1999 ident: 10.1016/j.immuni.2013.10.022_bib33 article-title: IL-6 induces long-term protective immunity against a lethal challenge of influenza virus publication-title: Vaccine doi: 10.1016/S0264-410X(98)00223-0 contributor: fullname: Lee – volume: 175 start-page: 131 year: 2005 ident: 10.1016/j.immuni.2013.10.022_bib23 article-title: Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction publication-title: J. Immunol. doi: 10.4049/jimmunol.175.1.131 contributor: fullname: Hu – volume: 38 start-page: 699 year: 2008 ident: 10.1016/j.immuni.2013.10.022_bib48 article-title: Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/rcmb.2007-0365OC contributor: fullname: Quinton – volume: 4 start-page: 386 year: 2004 ident: 10.1016/j.immuni.2013.10.022_bib42 article-title: Inhibition of IL-6 for the treatment of inflammatory diseases publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2004.03.005 contributor: fullname: Nishimoto – volume: 299 start-page: 1033 year: 2003 ident: 10.1016/j.immuni.2013.10.022_bib46 article-title: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells publication-title: Science doi: 10.1126/science.1078231 contributor: fullname: Pasare – volume: 182 start-page: 613 year: 2009 ident: 10.1016/j.immuni.2013.10.022_bib43 article-title: Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis publication-title: J. Immunol. doi: 10.4049/jimmunol.182.1.613 contributor: fullname: Nowell – volume: 4 start-page: 583 year: 2004 ident: 10.1016/j.immuni.2013.10.022_bib54 article-title: Fibrotic disease and the T(H)1/T(H)2 paradigm publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1412 contributor: fullname: Wynn – volume: 152 start-page: 3606 year: 1994 ident: 10.1016/j.immuni.2013.10.022_bib51 article-title: Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis publication-title: J. Immunol. doi: 10.4049/jimmunol.152.7.3606 contributor: fullname: Sempowski – volume: 357 start-page: 1608 year: 2007 ident: 10.1016/j.immuni.2013.10.022_bib21 article-title: STAT3 mutations in the hyper-IgE syndrome publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa073687 contributor: fullname: Holland – volume: 112 start-page: 598 year: 2003 ident: 10.1016/j.immuni.2013.10.022_bib36 article-title: Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation publication-title: J. Clin. Invest. doi: 10.1172/JCI17129 contributor: fullname: McLoughlin – volume: 19 start-page: 685 year: 2007 ident: 10.1016/j.immuni.2013.10.022_bib15 article-title: Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells publication-title: Int. Immunol. doi: 10.1093/intimm/dxm037 contributor: fullname: Finotto – volume: 8 start-page: 1363 year: 2007 ident: 10.1016/j.immuni.2013.10.022_bib52 article-title: Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 publication-title: Nat. Immunol. doi: 10.1038/ni1537 contributor: fullname: Stumhofer – volume: 110 start-page: 1503 year: 2002 ident: 10.1016/j.immuni.2013.10.022_bib22 article-title: Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS publication-title: J. Clin. Invest. doi: 10.1172/JCI0215841 contributor: fullname: Hong – volume: 214 start-page: 199 year: 2008 ident: 10.1016/j.immuni.2013.10.022_bib56 article-title: Cellular and molecular mechanisms of fibrosis publication-title: J. Pathol. doi: 10.1002/path.2277 contributor: fullname: Wynn – volume: 368 start-page: 339 year: 1994 ident: 10.1016/j.immuni.2013.10.022_bib32 article-title: Impaired immune and acute-phase responses in interleukin-6-deficient mice publication-title: Nature doi: 10.1038/368339a0 contributor: fullname: Kopf – volume: 171 start-page: 6198 year: 2003 ident: 10.1016/j.immuni.2013.10.022_bib35 article-title: Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils publication-title: J. Immunol. doi: 10.4049/jimmunol.171.11.6198 contributor: fullname: Matsukawa – volume: 175 start-page: 3463 year: 2005 ident: 10.1016/j.immuni.2013.10.022_bib27 article-title: Directing transition from innate to acquired immunity: defining a role for IL-6 publication-title: J. Immunol. doi: 10.4049/jimmunol.175.6.3463 contributor: fullname: Jones – volume: 15 start-page: 91 year: 2009 ident: 10.1016/j.immuni.2013.10.022_bib3 article-title: gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.01.002 contributor: fullname: Bollrath – volume: 181 start-page: 2189 year: 2008 ident: 10.1016/j.immuni.2013.10.022_bib14 article-title: IL-6 regulates neutrophil trafficking during acute inflammation via STAT3 publication-title: J. Immunol. doi: 10.4049/jimmunol.181.3.2189 contributor: fullname: Fielding – volume: 109 start-page: 2380 year: 2007 ident: 10.1016/j.immuni.2013.10.022_bib26 article-title: Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis publication-title: Blood doi: 10.1182/blood-2006-08-040352 contributor: fullname: Jenkins – volume: 448 start-page: 1058 year: 2007 ident: 10.1016/j.immuni.2013.10.022_bib39 article-title: Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome publication-title: Nature doi: 10.1038/nature06096 contributor: fullname: Minegishi – volume: 180 start-page: 647 year: 2008 ident: 10.1016/j.immuni.2013.10.022_bib47 article-title: Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6 publication-title: J. Immunol. doi: 10.4049/jimmunol.180.1.647 contributor: fullname: Puel – volume: 198 start-page: 1517 year: 2003 ident: 10.1016/j.immuni.2013.10.022_bib31 article-title: Endothelial cells require STAT3 for protection against endotoxin-induced inflammation publication-title: J. Exp. Med. doi: 10.1084/jem.20030077 contributor: fullname: Kano – volume: 83 start-page: 4167 year: 1986 ident: 10.1016/j.immuni.2013.10.022_bib50 article-title: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.83.12.4167 contributor: fullname: Roberts – volume: 11 start-page: 845 year: 2005 ident: 10.1016/j.immuni.2013.10.022_bib25 article-title: Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling publication-title: Nat. Med. doi: 10.1038/nm1282 contributor: fullname: Jenkins – volume: 181 start-page: 7243 year: 2008 ident: 10.1016/j.immuni.2013.10.022_bib40 article-title: Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis publication-title: J. Immunol. doi: 10.4049/jimmunol.181.10.7243 contributor: fullname: Mozaffarian – volume: 324 start-page: 73 year: 1986 ident: 10.1016/j.immuni.2013.10.022_bib19 article-title: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin publication-title: Nature doi: 10.1038/324073a0 contributor: fullname: Hirano – volume: 12 start-page: 1046 year: 2001 ident: 10.1016/j.immuni.2013.10.022_bib8 article-title: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.V1251046 contributor: fullname: Davies – volume: 186 start-page: 1199 year: 2011 ident: 10.1016/j.immuni.2013.10.022_bib16 article-title: IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3 publication-title: J. Immunol. doi: 10.4049/jimmunol.1002971 contributor: fullname: Greenhill – volume: 28 start-page: 589 year: 2008 ident: 10.1016/j.immuni.2013.10.022_bib41 article-title: Effect of IL-6 deficiency on susceptibility to HSV-1 respiratory infection and intrinsic macrophage antiviral resistance publication-title: J. Interferon Cytokine Res. doi: 10.1089/jir.2007.0103 contributor: fullname: Murphy – volume: 184 start-page: 2130 year: 2010 ident: 10.1016/j.immuni.2013.10.022_bib28 article-title: Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells publication-title: J. Immunol. doi: 10.4049/jimmunol.0901528 contributor: fullname: Jones – volume: 13 start-page: 470 year: 2002 ident: 10.1016/j.immuni.2013.10.022_bib53 article-title: Morphologic changes in the peritoneal membrane of patients with renal disease publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.V132470 contributor: fullname: Williams – volume: 131 start-page: 179 year: 2006 ident: 10.1016/j.immuni.2013.10.022_bib44 article-title: Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.04.025 contributor: fullname: Ogata – volume: 94 start-page: 703 year: 1998 ident: 10.1016/j.immuni.2013.10.022_bib59 article-title: Smad3 mutant mice develop metastatic colorectal cancer publication-title: Cell doi: 10.1016/S0092-8674(00)81730-4 contributor: fullname: Zhu – volume: 61 start-page: 399 year: 1993 ident: 10.1016/j.immuni.2013.10.022_bib38 article-title: Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model publication-title: Infect. Immun. doi: 10.1128/iai.61.2.399-410.1993 contributor: fullname: Mills – volume: 14 start-page: 705 year: 2001 ident: 10.1016/j.immuni.2013.10.022_bib24 article-title: IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation publication-title: Immunity doi: 10.1016/S1074-7613(01)00151-0 contributor: fullname: Hurst – volume: 131 start-page: 1073 year: 2006 ident: 10.1016/j.immuni.2013.10.022_bib30 article-title: STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.07.018 contributor: fullname: Judd – volume: 37 start-page: 3040 year: 2007 ident: 10.1016/j.immuni.2013.10.022_bib1 article-title: TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells publication-title: Eur. J. Immunol. doi: 10.1002/eji.200636483 contributor: fullname: Barr – volume: 13 start-page: 805 year: 2000 ident: 10.1016/j.immuni.2013.10.022_bib10 article-title: Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1 publication-title: Immunity doi: 10.1016/S1074-7613(00)00078-9 contributor: fullname: Diehl – volume: 15 start-page: 103 year: 2009 ident: 10.1016/j.immuni.2013.10.022_bib17 article-title: IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.01.001 contributor: fullname: Grivennikov – volume: 164 start-page: 4878 year: 2000 ident: 10.1016/j.immuni.2013.10.022_bib58 article-title: IL-6 is required for the development of Th1 cell-mediated murine colitis publication-title: J. Immunol. doi: 10.4049/jimmunol.164.9.4878 contributor: fullname: Yamamoto – volume: 185 start-page: 461 year: 1997 ident: 10.1016/j.immuni.2013.10.022_bib49 article-title: Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells publication-title: J. Exp. Med. doi: 10.1084/jem.185.3.461 contributor: fullname: Rincón – volume: 11 start-page: 498 year: 1996 ident: 10.1016/j.immuni.2013.10.022_bib7 article-title: Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis publication-title: Nephrol. Dial. Transplant. doi: 10.1093/oxfordjournals.ndt.a027318 contributor: fullname: Davies – volume: 115 start-page: 313 year: 2005 ident: 10.1016/j.immuni.2013.10.022_bib12 article-title: The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo publication-title: J. Clin. Invest. doi: 10.1172/JCI200522433 contributor: fullname: Doganci – volume: 121 start-page: 3375 year: 2011 ident: 10.1016/j.immuni.2013.10.022_bib29 article-title: Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling publication-title: J. Clin. Invest. doi: 10.1172/JCI57158 contributor: fullname: Jones – volume: 130 start-page: 373 year: 2006 ident: 10.1016/j.immuni.2013.10.022_bib5 article-title: Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.10.051 contributor: fullname: Chinen – volume: 4 start-page: e1000006 year: 2008 ident: 10.1016/j.immuni.2013.10.022_bib34 article-title: Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1000006 contributor: fullname: Longhi – volume: 66 start-page: 460 year: 2005 ident: 10.1016/j.immuni.2013.10.022_bib9 article-title: IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells publication-title: Hum. Immunol. doi: 10.1016/j.humimm.2005.01.012 contributor: fullname: Detournay – volume: 185 start-page: 2783 year: 2010 ident: 10.1016/j.immuni.2013.10.022_bib2 article-title: TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica publication-title: J. Immunol. doi: 10.4049/jimmunol.1001431 contributor: fullname: Barr – volume: 179 start-page: 2041 year: 2007 ident: 10.1016/j.immuni.2013.10.022_bib13 article-title: Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells publication-title: J. Immunol. doi: 10.4049/jimmunol.179.4.2041 contributor: fullname: Dominitzki – volume: 117 start-page: 524 year: 2007 ident: 10.1016/j.immuni.2013.10.022_bib55 article-title: Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases publication-title: J. Clin. Invest. doi: 10.1172/JCI31487 contributor: fullname: Wynn – volume: 21 start-page: 791 year: 1995 ident: 10.1016/j.immuni.2013.10.022_bib18 article-title: Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression publication-title: Exp. Lung Res. doi: 10.3109/01902149509050842 contributor: fullname: Gurujeyalakshmi – volume: 376 start-page: 594 year: 1995 ident: 10.1016/j.immuni.2013.10.022_bib57 article-title: An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection publication-title: Nature doi: 10.1038/376594a0 contributor: fullname: Wynn |
SSID | ssj0014590 |
Score | 2.6105669 |
Snippet | Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 40 |
SubjectTerms | Acute Disease Adoptive Transfer Animals Cells, Cultured Charitable foundations Chronic Disease Cytokines Disease Models, Animal Extracellular Matrix - immunology Feedback, Physiological Fibrosis Humans Interferon-gamma - genetics Interferon-gamma - metabolism Interleukin-6 - genetics Interleukin-6 - immunology Interleukin-6 - metabolism Mice Mice, Inbred C57BL Mice, Knockout Peritoneal dialysis Peritoneum - pathology Peritonitis - genetics Peritonitis - pathology Signal Transduction STAT1 Transcription Factor - genetics STAT1 Transcription Factor - metabolism Th1 Cells - immunology Th1 Cells - transplantation Viral infections |
Title | Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation |
URI | https://dx.doi.org/10.1016/j.immuni.2013.10.022 https://www.ncbi.nlm.nih.gov/pubmed/24412616 https://www.proquest.com/docview/1504271339 https://search.proquest.com/docview/1490901309 https://search.proquest.com/docview/1534812285 https://pubmed.ncbi.nlm.nih.gov/PMC3919204 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6IRAvCMZXYaAgwdOUKHbzYT-WfrAJygMdYm-RmzhbRknR2iLx33OXc9JmFZ8SL1FlX1vn7mzf2b-7Y-zlTEfgV_Rg9YtTcFBgC3Bl2jPuDJPPpTPp51UC0-Np_P5MDkfBqNOpKzVt2v6rpKENZI2Rs38h7eZHoQE-g8zhCVKH5x_JvTrim5v156J0o6NpcY6Wdnl-NLyqEsyOwT1eYBKSogR7E3ztxfybQURwDqrxZSMma6-eVOEjqwoS0IR3UYzPcultHSOMEQln66MMMHx9IF71_b63QejYmgBvsKzuBXV_aron6TssF2Srx3_ALNNzopls01iUMtAW9lLJHlhwBLm4FE9Jp2h1JE0L6Em40IjiUj1j21TsBpwqPdWrNSV3amklLb22gzZxSma7sz3QScWlV1TMQ2Bfz0NsH4VGX0u8PcUx4ZDwxg_MzLM9dkPAcoYVGoYnb5u7qiBUfoNsBfI6QLNCEe7-088MoF0H5zpOd8vwOb3L7liPxemTqt1jHVMesJtUw_T7Abs1seiM--x1S_ecRvcc0j2n1j2nKJ2N7jnbuveAfRyPTgfHrq3R4aZg6K9clUnFdShCrTIljNEyC7UIjOQ5THQ_jpUSfpBFsFdk4HrzUMs0j2RuuNSp4br3kO2XoIGPmcOzXObhLDBa-2CkGwWmbA4NIlNgJedxl7k145KvlIolqTGKlwkxOkFGYyswusvimruJNSfJTExAHX7zzcNaGImd2ssEPKdA4JGO6rIXTTcsxnjDpkuzWANNAINGLMCvaEKMfRdChl32iOTbvA7Y2lxEPIKhtyTfEGAy-HZPWVxUSeF7iiOnn_zzSz9ltzez9ZDtr67W5hnbW2br55W-_wBG4dKf |
link.rule.ids | 230,315,782,786,887,27934,27935 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin-6+Signaling+Drives+Fibrosis+in+Unresolved+Inflammation&rft.jtitle=Immunity+%28Cambridge%2C+Mass.%29&rft.au=Fielding%2C+Ceri%C2%A0A.&rft.au=Jones%2C+Gareth%C2%A0W.&rft.au=McLoughlin%2C+Rachel%C2%A0M.&rft.au=McLeod%2C+Louise&rft.date=2014-01-16&rft.pub=Elsevier+Inc&rft.issn=1074-7613&rft.eissn=1097-4180&rft.volume=40&rft.issue=1&rft.spage=40&rft.epage=50&rft_id=info:doi/10.1016%2Fj.immuni.2013.10.022&rft.externalDocID=S107476131300561X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1074-7613&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1074-7613&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1074-7613&client=summon |